These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24531229)

  • 1. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
    Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
    J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P; Subra G; Verdie P; Gabzdyl E; Bojarski AJ; Duszyńska B; Martinez J; Pawłowski M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4827-31. PubMed ID: 19560916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.
    Mewshaw RE; Zhou D; Zhou P; Shi X; Hornby G; Spangler T; Scerni R; Smith D; Schechter LE; Andree TH
    J Med Chem; 2004 Jul; 47(15):3823-42. PubMed ID: 15239661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.
    Moritomo A; Yamada H; Watanabe T; Itahana H; Akuzawa S; Okada M; Ohta M
    Bioorg Med Chem; 2013 Dec; 21(24):7841-52. PubMed ID: 24189186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity.
    Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G
    J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular entrance provides selectivity to serotonin 5-HT7 receptor antagonists with antidepressant-like behavior in vivo.
    Medina RA; Vázquez-Villa H; Gómez-Tamayo JC; Benhamú B; Martín-Fontecha M; de la Fuente T; Caltabiano G; Hedlund PB; Pardo L; López-Rodríguez ML
    J Med Chem; 2014 Aug; 57(15):6879-84. PubMed ID: 25073094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
    Bernotas RC; Antane S; Shenoy R; Le VD; Chen P; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1657-60. PubMed ID: 20138763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV; Deshpande AD; Kambhampati R; Badange RK; Kota L; Daulatabad AV; Shinde AK; Ahmad I; Kandikere V; Jayarajan P; Dubey PK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):346-9. PubMed ID: 21134749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT(4) receptor ligands.
    Diouf O; Depreux P; Chavatte P; Poupaert JH
    Eur J Med Chem; 2000; 35(7-8):699-706. PubMed ID: 10960185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Mitkin OD; Tkachenko SE; Okun IM; Kysil VM
    Eur J Med Chem; 2010 Feb; 45(2):782-9. PubMed ID: 19939513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin (5-HT) regulates neurite outgrowth through 5-HT1A and 5-HT7 receptors in cultured hippocampal neurons.
    Rojas PS; Neira D; Muñoz M; Lavandero S; Fiedler JL
    J Neurosci Res; 2014 Aug; 92(8):1000-9. PubMed ID: 24752854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4 methyl piperazine as a positive ionizable group.
    Hayat F; Cho S; Rhim H; Indu Viswanath AN; Pae AN; Lee JY; Choo DJ; Choo HY
    Bioorg Med Chem; 2013 Sep; 21(17):5573-82. PubMed ID: 23810425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-aminotetralin and 3-aminochroman derivatives as selective serotonin 5-HT7 receptor agonists and antagonists.
    Holmberg P; Sohn D; Leideborg R; Caldirola P; Zlatoidsky P; Hanson S; Mohell N; Rosqvist S; Nordvall G; Johansson AM; Johansson R
    J Med Chem; 2004 Jul; 47(16):3927-30. PubMed ID: 15267230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.